Literature DB >> 31488543

Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.

Junsuk Ko1,2, Tingting Mills1, Jingjing Huang3, Ning-Yuan Chen1, Tinne C J Mertens1, Scott D Collum1,2, Garam Lee1, Yu Xiang1, Leng Han1,2, Yang Zhou4, Chun Geun Lee4, Jack A Elias4, Soma S K Jyothula5, Keshava Rajagopal5, Harry Karmouty-Quintana1,2, Michael R Blackburn6,2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by the pathological remodeling of air sacs as a result of excessive accumulation of extracellular matrix (ECM) proteins, but the mechanism governing the robust protein expression is poorly understood. Our recent findings demonstrate that alternative polyadenylation (APA) caused by NUDT21 reduction is important for the increased expression of fibrotic mediators and ECM proteins in lung fibroblasts by shortening the 3'-untranslated regions (3'-UTRs) of mRNAs and stabilizing their transcripts, therefore activating pathological signaling pathways. Despite the importance of NUDT21 reduction in the regulation of fibrosis, the underlying mechanisms for the depletion are unknown. We demonstrate here that NUDT21 is depleted by TGFβ1. We found that miR203, which is increased in IPF, was induced by TGFβ1 to target the NUDT21 3'-UTR, thus depleting NUDT21 in human and mouse lung fibroblasts. TGFβ1-mediated NUDT21 reduction was attenuated by the miR203 inhibitor antagomiR203 in fibroblasts. TGFβ1 transgenic mice revealed that TGFβ1 down-regulates NUDT21 in fibroblasts in vivo Furthermore, TGFβ1 promoted differential APA of fibrotic genes, including FGF14, RICTOR, TMOD2, and UCP5, in association with increased protein expression. This unique differential APA signature was also observed in IPF fibroblasts. Altogether, our results identified TGFβ1 as an APA regulator through NUDT21 depletion amplifying pulmonary fibrosis.
© 2019 Ko et al.

Entities:  

Keywords:  APA; NUDT21; alternative polyadenylation; mRNA; miR203; polyadenylation; post-transcriptional regulation; pulmonary fibrosis; transforming growth factor β (TGFβ)

Mesh:

Substances:

Year:  2019        PMID: 31488543      PMCID: PMC6816088          DOI: 10.1074/jbc.RA119.009148

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12.

Authors:  Hye-Ryun Kang; Soo Jung Cho; Chun Geun Lee; Robert J Homer; Jack A Elias
Journal:  J Biol Chem       Date:  2007-01-05       Impact factor: 5.157

2.  Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Vidya Bodempudi; Alexey Benyumov; Polla Hergert; Damien Tank; Jeremy Herrera; Jeff Braziunas; Ola Larsson; Matthew Parker; Daniel Rossi; Karen Smith; Mark Peterson; Andrew Limper; Jose Jessurun; John Connett; David Ingbar; Sem Phan; Peter B Bitterman; Craig A Henke
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

3.  Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.

Authors:  Zheng Xia; Lawrence A Donehower; Thomas A Cooper; Joel R Neilson; David A Wheeler; Eric J Wagner; Wei Li
Journal:  Nat Commun       Date:  2014-11-20       Impact factor: 14.919

4.  NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.

Authors:  Sheng Tan; Hua Li; Weijie Zhang; Yunying Shao; Yuan Liu; Haiyang Guan; Jun Wu; Yani Kang; Junsong Zhao; Qing Yu; Yunzhao Gu; Keshuo Ding; Min Zhang; Wenchang Qian; Yong Zhu; Huayong Cai; Changyu Chen; Peter E Lobie; Xiaodong Zhao; Jielin Sun; Tao Zhu
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

Review 5.  Targeting TGF-β signaling for the treatment of fibrosis.

Authors:  Andrea Hermina Györfi; Alexandru-Emil Matei; Jörg H W Distler
Journal:  Matrix Biol       Date:  2018-01-31       Impact factor: 11.583

6.  Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.

Authors:  Kevin R Flaherty; Thomas V Colby; William D Travis; Galen B Toews; Jeanette Mumford; Susan Murray; Victor J Thannickal; Ella A Kazerooni; Barry H Gross; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

7.  Cistrome: an integrative platform for transcriptional regulation studies.

Authors:  Tao Liu; Jorge A Ortiz; Len Taing; Clifford A Meyer; Bernett Lee; Yong Zhang; Hyunjin Shin; Swee S Wong; Jian Ma; Ying Lei; Utz J Pape; Michael Poidinger; Yiwen Chen; Kevin Yeung; Myles Brown; Yaron Turpaz; X Shirley Liu
Journal:  Genome Biol       Date:  2011-08-22       Impact factor: 13.583

Review 8.  Alternative Polyadenylation of mRNAs: 3'-Untranslated Region Matters in Gene Expression.

Authors:  Hsin-Sung Yeh; Jeongsik Yong
Journal:  Mol Cells       Date:  2016-02-25       Impact factor: 5.034

9.  CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.

Authors:  Chioniso P Masamha; Zheng Xia; Jingxuan Yang; Todd R Albrecht; Min Li; Ann-Bin Shyu; Wei Li; Eric J Wagner
Journal:  Nature       Date:  2014-05-11       Impact factor: 49.962

Review 10.  Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy.

Authors:  George A Margaritopoulos; Eirini Vasarmidi; Katerina M Antoniou
Journal:  Core Evid       Date:  2016-07-01
View more
  6 in total

1.  Stiff matrix instigates type I collagen biogenesis by mammalian cleavage factor I complex-mediated alternative polyadenylation.

Authors:  Zijing Zhou; Jing Qu; Li He; Yi Zhu; Shan-Zhong Yang; Feng Zhang; Ting Guo; Hong Peng; Ping Chen; Yong Zhou
Journal:  JCI Insight       Date:  2020-02-13

Review 2.  Emerging Roles of RNA 3'-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders.

Authors:  Jamie Nourse; Stefano Spada; Sven Danckwardt
Journal:  Biomolecules       Date:  2020-06-17

3.  Catalpol Protects Against Pulmonary Fibrosis Through Inhibiting TGF-β1/Smad3 and Wnt/β-Catenin Signaling Pathways.

Authors:  Fan Yang; Zhen-Feng Hou; Hao-Yue Zhu; Xiao-Xuan Chen; Wan-Yang Li; Ren-Shuang Cao; Yu-Xuan Li; Ru Chen; Wei Zhang
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 4.  TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review).

Authors:  Zhimin Ye; Yongbin Hu
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

Review 5.  Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.

Authors:  Thị Hằng Giang Phan; Panagiotis Paliogiannis; Gheyath K Nasrallah; Roberta Giordo; Ali Hussein Eid; Alessandro Giuseppe Fois; Angelo Zinellu; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

6.  Integrating RNA-Seq With GWAS Reveals a Novel SNP in Immune-Related HLA-DQB1 Gene Associated With Occupational Pulmonary Fibrosis Risk: A Multi-Stage Study.

Authors:  Yan Zhou; Yingyi Zhang; Rui Zhao; Zhounan Cheng; Minzhu Tang; Anni Qiu; Yang Dong; Yihua Lu; Yulong Lian; Xun Zhuang; Tian Tian; Wei Wang; Minjie Chu
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.